… of confirmed symptomatic COVID‐19, severe and critical COVID‐19, and serious … efficacy
of COVID‐19 vaccines, and this review is updated regularly on the COVID‐NMA platform (covid…

… This study evaluated the safety and effectiveness of the COVID-19 vaccine through systematic
literature review and qualitative analysis for the published COVID-19 vaccine clinical trial …

… Several vaccines against coronavirus disease 2019 (COVID-19) are on the cusp of regulatory
approval. Their safety and efficacy in older people is critical to their success. Even though …

… efficacy and safety of COVID-19 vaccines using published clinical trial data and real-world
data. We comprehensively analyzed the efficacy of the existing COVID-19 … that the efficacy of …

… samples obtained from patients with Covid-19 in the southeast of … our current attempts at
controlling Covid-19 and lead to … to be safe and 89.7% effective against symptomatic Covid-19 …

… Here, we report safety and efficacy findings from the phase 2/3 part of a global phase 1/2/3 …
the safety, immunogenicity, and efficacy of 30 μg of BNT162b2 in preventing Covid-19 in …

… BNT162b2 had a favorable safety … Safety, efficacy, and immunogenicity data from participants
12 to 15 years of age in this trial have been reported. Here, we report safety and efficacy …

… test of proportions, a vaccine efficacy of 95% was not demonstrated… Covid-19–positive
patients in whom severe disease developed to assess vaccine protection against severe Covid-19…

… Here, we report the clinical efficacy of an RBD-based Covid-19 vaccine and add a piece
to the puzzle in understanding one of the major viral targets used in Covid-19 vaccines. …

… ’ safety, efficacy, and immunogenicity against SARS-CoV-2. Here, we mainly focused on
available RCTs publications on the safety, efficacy, and immunogenicity of COVID-19 vaccines. …